Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hider

Showing results (401-410 of 688) with videos related to

Pageof 69
Sort By:
The Pharmacogenomics Journal|March 28, 2012
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patientsS A Owen, S L Hider, P Martin, et al.
Acta Haematologica|January 1, 1987
In vivo evaluation of hydroxypyridone iron chelators in a mouse modelM Gyparaki, J B Porter, S Hirani, et al.
The New Zealand Medical Journal|July 25, 1984
Diabetes mellitus in a Christchurch working populationC R Brown, P N Hider, R S Scott, et al.
Experimental Hematology|January 1, 1993
In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesisK P Hoyes, H M Jones, R D Abeysinghe, et al.
Blood|January 1, 1992
Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron storesS Zevin, G Link, R W Grady, et al.
Health Policy (Amsterdam, Netherlands)|March 30, 2013
Efficiency, effectiveness, equity (E3). Evaluating hospital performance in three dimensionsPeter Davis, Barry Milne, Karl Parker, et al.
Biochemical Pharmacology|March 15, 1990
Facilitated uptake of zinc into human erythrocytes. Relevance to the treatment of sickle-cell anaemiaR C Hider, L Ejim, P D Taylor, et al.
Haematologica|October 15, 2020
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathwaysMaciej W Garbowski, Sukhvinder Bansal, John B Porter, et al.
Clinical Rheumatology|June 3, 2017
How common is depression in patients with polymyalgia rheumatica?Arani Vivekanantham, Milica Blagojevic-Bucknall, Kris Clarkson, et al.
Rheumatology Advances in Practice|June 18, 2026
Impact of interventions to prevent anxiety and depression in people with inflammatory rheumatological conditions: a systematic reviewLauren Gray, Matilda Bjorklund, Samantha L Hider, et al.
Pageof 69

Showing results (401-410 of 688) with videos related to

Sort By:
Pageof 69
The Pharmacogenomics Journal|March 28, 2012
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patientsS A Owen, S L Hider, P Martin, et al.
Acta Haematologica|January 1, 1987
In vivo evaluation of hydroxypyridone iron chelators in a mouse modelM Gyparaki, J B Porter, S Hirani, et al.
The New Zealand Medical Journal|July 25, 1984
Diabetes mellitus in a Christchurch working populationC R Brown, P N Hider, R S Scott, et al.
Experimental Hematology|January 1, 1993
In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesisK P Hoyes, H M Jones, R D Abeysinghe, et al.
Blood|January 1, 1992
Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron storesS Zevin, G Link, R W Grady, et al.
Health Policy (Amsterdam, Netherlands)|March 30, 2013
Efficiency, effectiveness, equity (E3). Evaluating hospital performance in three dimensionsPeter Davis, Barry Milne, Karl Parker, et al.
Biochemical Pharmacology|March 15, 1990
Facilitated uptake of zinc into human erythrocytes. Relevance to the treatment of sickle-cell anaemiaR C Hider, L Ejim, P D Taylor, et al.
Haematologica|October 15, 2020
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathwaysMaciej W Garbowski, Sukhvinder Bansal, John B Porter, et al.
Clinical Rheumatology|June 3, 2017
How common is depression in patients with polymyalgia rheumatica?Arani Vivekanantham, Milica Blagojevic-Bucknall, Kris Clarkson, et al.
Rheumatology Advances in Practice|June 18, 2026
Impact of interventions to prevent anxiety and depression in people with inflammatory rheumatological conditions: a systematic reviewLauren Gray, Matilda Bjorklund, Samantha L Hider, et al.
Pageof 69